nodes	percent_of_prediction	percent_of_DWPC	metapath
Methotrexate—ALB—pancreatitis	0.386	1	CbGaD
Methotrexate—ABCC3—bile duct—pancreatitis	0.0186	0.106	CbGeAlD
Methotrexate—Speech impairment NOS—Hyoscyamine—pancreatitis	0.0151	0.1	CcSEcCtD
Methotrexate—FOLR1—exocrine gland—pancreatitis	0.015	0.0858	CbGeAlD
Methotrexate—ABCC2—bile duct—pancreatitis	0.0149	0.085	CbGeAlD
Methotrexate—ABCC2—bile—pancreatitis	0.0114	0.0653	CbGeAlD
Methotrexate—Loss of libido—Hyoscyamine—pancreatitis	0.00716	0.0474	CcSEcCtD
Methotrexate—FPGS—islet of Langerhans—pancreatitis	0.00484	0.0276	CbGeAlD
Methotrexate—Paralysis—Hyoscyamine—pancreatitis	0.00476	0.0315	CcSEcCtD
Methotrexate—FOLR1—blood—pancreatitis	0.00474	0.0271	CbGeAlD
Methotrexate—Cyanosis—Hyoscyamine—pancreatitis	0.00467	0.0309	CcSEcCtD
Methotrexate—Stupor—Hyoscyamine—pancreatitis	0.00443	0.0293	CcSEcCtD
Methotrexate—SLC19A1—digestive system—pancreatitis	0.00436	0.0249	CbGeAlD
Methotrexate—SLC19A1—blood—pancreatitis	0.00416	0.0237	CbGeAlD
Methotrexate—AOX1—gall bladder—pancreatitis	0.00406	0.0232	CbGeAlD
Methotrexate—Petechiae—Hyoscyamine—pancreatitis	0.00402	0.0266	CcSEcCtD
Methotrexate—ABCC3—gall bladder—pancreatitis	0.00397	0.0227	CbGeAlD
Methotrexate—GGH—pancreas—pancreatitis	0.00387	0.0221	CbGeAlD
Methotrexate—Speech disorder—Hyoscyamine—pancreatitis	0.00384	0.0254	CcSEcCtD
Methotrexate—Erectile dysfunction—Propantheline—pancreatitis	0.00373	0.0247	CcSEcCtD
Methotrexate—Drowsiness—Propantheline—pancreatitis	0.00361	0.0239	CcSEcCtD
Methotrexate—Dysarthria—Hyoscyamine—pancreatitis	0.00349	0.0231	CcSEcCtD
Methotrexate—ALB—gall bladder—pancreatitis	0.00339	0.0193	CbGeAlD
Methotrexate—Respiratory failure—Hyoscyamine—pancreatitis	0.00337	0.0223	CcSEcCtD
Methotrexate—SLC46A1—digestive system—pancreatitis	0.00336	0.0192	CbGeAlD
Methotrexate—GGH—digestive system—pancreatitis	0.00331	0.0189	CbGeAlD
Methotrexate—ATIC—pancreas—pancreatitis	0.00329	0.0188	CbGeAlD
Methotrexate—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00319	0.0211	CcSEcCtD
Methotrexate—Skin exfoliation—Hyoscyamine—pancreatitis	0.00316	0.0209	CcSEcCtD
Methotrexate—GGH—blood—pancreatitis	0.00315	0.018	CbGeAlD
Methotrexate—PGD—islet of Langerhans—pancreatitis	0.00302	0.0173	CbGeAlD
Methotrexate—Coma—Hyoscyamine—pancreatitis	0.00302	0.02	CcSEcCtD
Methotrexate—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00294	0.0195	CcSEcCtD
Methotrexate—FPGS—digestive system—pancreatitis	0.00291	0.0166	CbGeAlD
Methotrexate—ATIC—digestive system—pancreatitis	0.00281	0.016	CbGeAlD
Methotrexate—SLCO4C1—blood—pancreatitis	0.00279	0.0159	CbGeAlD
Methotrexate—FPGS—blood—pancreatitis	0.00277	0.0158	CbGeAlD
Methotrexate—ATIC—blood—pancreatitis	0.00268	0.0153	CbGeAlD
Methotrexate—AOX1—islet of Langerhans—pancreatitis	0.00266	0.0152	CbGeAlD
Methotrexate—Vision blurred—Propantheline—pancreatitis	0.00266	0.0176	CcSEcCtD
Methotrexate—Lethargy—Hyoscyamine—pancreatitis	0.00245	0.0162	CcSEcCtD
Methotrexate—Osteoarthritis—Hyoscyamine—pancreatitis	0.0024	0.0159	CcSEcCtD
Methotrexate—Confusional state—Propantheline—pancreatitis	0.00232	0.0154	CcSEcCtD
Methotrexate—Anaphylactic shock—Propantheline—pancreatitis	0.0023	0.0152	CcSEcCtD
Methotrexate—Irritability—Hyoscyamine—pancreatitis	0.00229	0.0152	CcSEcCtD
Methotrexate—SLC22A11—digestive system—pancreatitis	0.00227	0.013	CbGeAlD
Methotrexate—Ataxia—Hyoscyamine—pancreatitis	0.00226	0.0149	CcSEcCtD
Methotrexate—SLC22A7—digestive system—pancreatitis	0.00222	0.0126	CbGeAlD
Methotrexate—MTHFR—digestive system—pancreatitis	0.00209	0.0119	CbGeAlD
Methotrexate—Insomnia—Propantheline—pancreatitis	0.00208	0.0138	CcSEcCtD
Methotrexate—Somnolence—Propantheline—pancreatitis	0.00205	0.0136	CcSEcCtD
Methotrexate—MTHFR—blood—pancreatitis	0.00199	0.0114	CbGeAlD
Methotrexate—SLCO3A1—blood—pancreatitis	0.00196	0.0112	CbGeAlD
Methotrexate—Dysuria—Hyoscyamine—pancreatitis	0.00194	0.0128	CcSEcCtD
Methotrexate—Erectile dysfunction—Hyoscyamine—pancreatitis	0.00191	0.0126	CcSEcCtD
Methotrexate—TYMS—digestive system—pancreatitis	0.00191	0.0109	CbGeAlD
Methotrexate—Feeling abnormal—Propantheline—pancreatitis	0.0019	0.0126	CcSEcCtD
Methotrexate—DHFR—digestive system—pancreatitis	0.00189	0.0108	CbGeAlD
Methotrexate—AOX1—pancreas—pancreatitis	0.00187	0.0107	CbGeAlD
Methotrexate—Drowsiness—Hyoscyamine—pancreatitis	0.00185	0.0122	CcSEcCtD
Methotrexate—Depression—Hyoscyamine—pancreatitis	0.00184	0.0122	CcSEcCtD
Methotrexate—Urticaria—Propantheline—pancreatitis	0.00183	0.0121	CcSEcCtD
Methotrexate—TYMS—blood—pancreatitis	0.00182	0.0104	CbGeAlD
Methotrexate—PGD—digestive system—pancreatitis	0.00181	0.0104	CbGeAlD
Methotrexate—DHFR—blood—pancreatitis	0.0018	0.0103	CbGeAlD
Methotrexate—Conjunctivitis—Hyoscyamine—pancreatitis	0.0018	0.0119	CcSEcCtD
Methotrexate—Sweating—Hyoscyamine—pancreatitis	0.00177	0.0117	CcSEcCtD
Methotrexate—PGD—blood—pancreatitis	0.00173	0.00987	CbGeAlD
Methotrexate—Hypersensitivity—Propantheline—pancreatitis	0.0017	0.0112	CcSEcCtD
Methotrexate—SLC16A1—digestive system—pancreatitis	0.00169	0.00967	CbGeAlD
Methotrexate—Asthenia—Propantheline—pancreatitis	0.00165	0.0109	CcSEcCtD
Methotrexate—SLCO1B1—digestive system—pancreatitis	0.00165	0.00941	CbGeAlD
Methotrexate—AOX1—digestive system—pancreatitis	0.0016	0.00913	CbGeAlD
Methotrexate—SLCO1B1—blood—pancreatitis	0.00157	0.00896	CbGeAlD
Methotrexate—ABCC3—digestive system—pancreatitis	0.00156	0.00893	CbGeAlD
Methotrexate—ABCC10—digestive system—pancreatitis	0.00156	0.00888	CbGeAlD
Methotrexate—Dizziness—Propantheline—pancreatitis	0.00152	0.0101	CcSEcCtD
Methotrexate—ABCC4—pancreas—pancreatitis	0.00151	0.00863	CbGeAlD
Methotrexate—ABCC3—blood—pancreatitis	0.00149	0.0085	CbGeAlD
Methotrexate—ABCC10—blood—pancreatitis	0.00148	0.00846	CbGeAlD
Methotrexate—Vomiting—Propantheline—pancreatitis	0.00146	0.00969	CcSEcCtD
Methotrexate—Mental disorder—Hyoscyamine—pancreatitis	0.00145	0.00963	CcSEcCtD
Methotrexate—Rash—Propantheline—pancreatitis	0.00145	0.00961	CcSEcCtD
Methotrexate—Dermatitis—Propantheline—pancreatitis	0.00145	0.00961	CcSEcCtD
Methotrexate—Erythema—Hyoscyamine—pancreatitis	0.00145	0.00956	CcSEcCtD
Methotrexate—Headache—Propantheline—pancreatitis	0.00144	0.00955	CcSEcCtD
Methotrexate—Dysgeusia—Hyoscyamine—pancreatitis	0.00142	0.00937	CcSEcCtD
Methotrexate—Nausea—Propantheline—pancreatitis	0.00137	0.00906	CcSEcCtD
Methotrexate—Vision blurred—Hyoscyamine—pancreatitis	0.00136	0.00901	CcSEcCtD
Methotrexate—SLCO1A2—digestive system—pancreatitis	0.00134	0.00766	CbGeAlD
Methotrexate—Vertigo—Hyoscyamine—pancreatitis	0.0013	0.00859	CcSEcCtD
Methotrexate—ABCC4—digestive system—pancreatitis	0.00129	0.00737	CbGeAlD
Methotrexate—Convulsion—Hyoscyamine—pancreatitis	0.00125	0.00829	CcSEcCtD
Methotrexate—ABCC2—digestive system—pancreatitis	0.00125	0.00713	CbGeAlD
Methotrexate—Chest pain—Hyoscyamine—pancreatitis	0.00123	0.00814	CcSEcCtD
Methotrexate—ABCC4—blood—pancreatitis	0.00123	0.00702	CbGeAlD
Methotrexate—SLC22A8—blood—pancreatitis	0.00122	0.00696	CbGeAlD
Methotrexate—ABCC2—blood—pancreatitis	0.00119	0.00679	CbGeAlD
Methotrexate—Confusional state—Hyoscyamine—pancreatitis	0.00119	0.00787	CcSEcCtD
Methotrexate—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00118	0.00781	CcSEcCtD
Methotrexate—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00114	0.00755	CcSEcCtD
Methotrexate—Hypotension—Hyoscyamine—pancreatitis	0.0011	0.00729	CcSEcCtD
Methotrexate—Insomnia—Hyoscyamine—pancreatitis	0.00107	0.00706	CcSEcCtD
Methotrexate—Dyspnoea—Hyoscyamine—pancreatitis	0.00105	0.00696	CcSEcCtD
Methotrexate—Somnolence—Hyoscyamine—pancreatitis	0.00105	0.00694	CcSEcCtD
Methotrexate—ABCC1—blood—pancreatitis	0.00105	0.00599	CbGeAlD
Methotrexate—Dyspepsia—Hyoscyamine—pancreatitis	0.00104	0.00687	CcSEcCtD
Methotrexate—Fatigue—Hyoscyamine—pancreatitis	0.00102	0.00673	CcSEcCtD
Methotrexate—Pain—Hyoscyamine—pancreatitis	0.00101	0.00667	CcSEcCtD
Methotrexate—Feeling abnormal—Hyoscyamine—pancreatitis	0.000972	0.00643	CcSEcCtD
Methotrexate—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000964	0.00638	CcSEcCtD
Methotrexate—Urticaria—Hyoscyamine—pancreatitis	0.000937	0.0062	CcSEcCtD
Methotrexate—Abdominal pain—Hyoscyamine—pancreatitis	0.000932	0.00617	CcSEcCtD
Methotrexate—Body temperature increased—Hyoscyamine—pancreatitis	0.000932	0.00617	CcSEcCtD
Methotrexate—Hypersensitivity—Hyoscyamine—pancreatitis	0.000869	0.00575	CcSEcCtD
Methotrexate—ABCG2—blood—pancreatitis	0.000868	0.00496	CbGeAlD
Methotrexate—Asthenia—Hyoscyamine—pancreatitis	0.000846	0.0056	CcSEcCtD
Methotrexate—Pruritus—Hyoscyamine—pancreatitis	0.000834	0.00552	CcSEcCtD
Methotrexate—Diarrhoea—Hyoscyamine—pancreatitis	0.000807	0.00534	CcSEcCtD
Methotrexate—Dizziness—Hyoscyamine—pancreatitis	0.00078	0.00516	CcSEcCtD
Methotrexate—Vomiting—Hyoscyamine—pancreatitis	0.00075	0.00496	CcSEcCtD
Methotrexate—ABCB1—islet of Langerhans—pancreatitis	0.000748	0.00427	CbGeAlD
Methotrexate—Rash—Hyoscyamine—pancreatitis	0.000744	0.00492	CcSEcCtD
Methotrexate—Dermatitis—Hyoscyamine—pancreatitis	0.000743	0.00492	CcSEcCtD
Methotrexate—Headache—Hyoscyamine—pancreatitis	0.000739	0.00489	CcSEcCtD
Methotrexate—Nausea—Hyoscyamine—pancreatitis	0.000701	0.00464	CcSEcCtD
Methotrexate—ABCB1—pancreas—pancreatitis	0.000526	0.003	CbGeAlD
Methotrexate—ABCB1—digestive system—pancreatitis	0.000449	0.00256	CbGeAlD
Methotrexate—ABCB1—blood—pancreatitis	0.000428	0.00244	CbGeAlD
Methotrexate—ABCC3—Metabolism—A2M—pancreatitis	5.7e-05	0.000198	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—MDM2—pancreatitis	5.69e-05	0.000198	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	5.64e-05	0.000196	CbGpPWpGaD
Methotrexate—AOX1—Disease—LPL—pancreatitis	5.63e-05	0.000196	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	5.63e-05	0.000196	CbGpPWpGaD
Methotrexate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatitis	5.63e-05	0.000196	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—SERPINA1—pancreatitis	5.62e-05	0.000195	CbGpPWpGaD
Methotrexate—SLC22A11—Transmembrane transport of small molecules—ALB—pancreatitis	5.59e-05	0.000194	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—KRAS—pancreatitis	5.55e-05	0.000193	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ADH1B—pancreatitis	5.51e-05	0.000191	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—PTGS2—pancreatitis	5.49e-05	0.000191	CbGpPWpGaD
Methotrexate—FPGS—Disease—NRAS—pancreatitis	5.48e-05	0.000191	CbGpPWpGaD
Methotrexate—SLC16A1—Transmembrane transport of small molecules—ALB—pancreatitis	5.48e-05	0.00019	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—TRPV1—pancreatitis	5.47e-05	0.00019	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—FGA—pancreatitis	5.47e-05	0.00019	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—GCG—pancreatitis	5.47e-05	0.00019	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—XDH—pancreatitis	5.47e-05	0.00019	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—LPL—pancreatitis	5.45e-05	0.00019	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—A2M—pancreatitis	5.44e-05	0.000189	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PPARG—pancreatitis	5.34e-05	0.000186	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—ALB—pancreatitis	5.25e-05	0.000183	CbGpPWpGaD
Methotrexate—PGD—Metabolism—INS—pancreatitis	5.24e-05	0.000182	CbGpPWpGaD
Methotrexate—ALB—Metabolism—CTRB2—pancreatitis	5.24e-05	0.000182	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TGFB1—pancreatitis	5.23e-05	0.000182	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALDH2—pancreatitis	5.21e-05	0.000181	CbGpPWpGaD
Methotrexate—PGD—Disease—MDM2—pancreatitis	5.21e-05	0.000181	CbGpPWpGaD
Methotrexate—TYMS—Cell Cycle—MDM2—pancreatitis	5.19e-05	0.00018	CbGpPWpGaD
Methotrexate—ALB—Folate Metabolism—IL6—pancreatitis	5.19e-05	0.00018	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—LPL—pancreatitis	5.18e-05	0.00018	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PLA2G1B—pancreatitis	5.14e-05	0.000179	CbGpPWpGaD
Methotrexate—DHFR—Disease—LPL—pancreatitis	5.12e-05	0.000178	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—TNF—pancreatitis	5.11e-05	0.000178	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ADH1B—pancreatitis	5.1e-05	0.000177	CbGpPWpGaD
Methotrexate—FPGS—Disease—TGFB1—pancreatitis	5.09e-05	0.000177	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	5.08e-05	0.000177	CbGpPWpGaD
Methotrexate—SLC22A7—Transmembrane transport of small molecules—ALB—pancreatitis	5.07e-05	0.000176	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.06e-05	0.000176	CbGpPWpGaD
Methotrexate—PGD—Disease—PTGS2—pancreatitis	5.02e-05	0.000174	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—GCG—pancreatitis	4.98e-05	0.000173	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—FGB—pancreatitis	4.98e-05	0.000173	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—A2M—pancreatitis	4.96e-05	0.000172	CbGpPWpGaD
Methotrexate—ABCB1—Allograft Rejection—TNF—pancreatitis	4.88e-05	0.00017	CbGpPWpGaD
Methotrexate—ABCC1—Disease—FGA—pancreatitis	4.88e-05	0.000169	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—LPL—pancreatitis	4.83e-05	0.000168	CbGpPWpGaD
Methotrexate—SLCO1B3—Transmembrane transport of small molecules—ALB—pancreatitis	4.82e-05	0.000167	CbGpPWpGaD
Methotrexate—PGD—Metabolism—ALB—pancreatitis	4.81e-05	0.000167	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—GCG—pancreatitis	4.77e-05	0.000166	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—ALB—pancreatitis	4.72e-05	0.000164	CbGpPWpGaD
Methotrexate—FPGS—Disease—KRAS—pancreatitis	4.72e-05	0.000164	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—LPL—pancreatitis	4.72e-05	0.000164	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—HRAS—pancreatitis	4.72e-05	0.000164	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PLA2G1B—pancreatitis	4.62e-05	0.000161	CbGpPWpGaD
Methotrexate—SLC46A1—Metabolism—PTGS2—pancreatitis	4.6e-05	0.00016	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—CTRB2—pancreatitis	4.59e-05	0.000159	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—ALB—pancreatitis	4.57e-05	0.000159	CbGpPWpGaD
Methotrexate—ALB—Metabolism—FDX1—pancreatitis	4.54e-05	0.000158	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALDH2—pancreatitis	4.54e-05	0.000158	CbGpPWpGaD
Methotrexate—SLC19A1—Disease—IL6—pancreatitis	4.51e-05	0.000157	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—A2M—pancreatitis	4.47e-05	0.000155	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4.43e-05	0.000154	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	4.42e-05	0.000154	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PLA2G1B—pancreatitis	4.39e-05	0.000153	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—GCG—pancreatitis	4.38e-05	0.000152	CbGpPWpGaD
Methotrexate—ABCC3—Transmembrane transport of small molecules—ALB—pancreatitis	4.34e-05	0.000151	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PPP3CA—pancreatitis	4.32e-05	0.00015	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—NRAS—pancreatitis	4.31e-05	0.00015	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—LPL—pancreatitis	4.29e-05	0.000149	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—NRAS—pancreatitis	4.27e-05	0.000148	CbGpPWpGaD
Methotrexate—SLC22A8—Transmembrane transport of small molecules—ALB—pancreatitis	4.26e-05	0.000148	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—A2M—pancreatitis	4.24e-05	0.000147	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADH4—pancreatitis	4.22e-05	0.000147	CbGpPWpGaD
Methotrexate—PGD—Metabolism—PTGS2—pancreatitis	4.2e-05	0.000146	CbGpPWpGaD
Methotrexate—MTHFR—Disease—INS—pancreatitis	4.13e-05	0.000144	CbGpPWpGaD
Methotrexate—ALB—Selenium Micronutrient Network—IL6—pancreatitis	4.12e-05	0.000143	CbGpPWpGaD
Methotrexate—ABCC4—Transmembrane transport of small molecules—ALB—pancreatitis	4.08e-05	0.000142	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALDH2—pancreatitis	4.08e-05	0.000142	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PLA2G1B—pancreatitis	4.07e-05	0.000141	CbGpPWpGaD
Methotrexate—AOX1—Disease—INS—pancreatitis	4.03e-05	0.00014	CbGpPWpGaD
Methotrexate—FPGS—Disease—HRAS—pancreatitis	4.01e-05	0.000139	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—TGFB1—pancreatitis	4e-05	0.000139	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4e-05	0.000139	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.98e-05	0.000138	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	3.98e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—FDX1—pancreatitis	3.98e-05	0.000138	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KNG1—pancreatitis	3.98e-05	0.000138	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PRSS1—pancreatitis	3.97e-05	0.000138	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—TGFB1—pancreatitis	3.97e-05	0.000138	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—GCG—pancreatitis	3.95e-05	0.000137	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—A2M—pancreatitis	3.93e-05	0.000137	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—LPL—pancreatitis	3.91e-05	0.000136	CbGpPWpGaD
Methotrexate—PGD—Disease—NRAS—pancreatitis	3.91e-05	0.000136	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALDH2—pancreatitis	3.88e-05	0.000135	CbGpPWpGaD
Methotrexate—FPGS—Disease—IL6—pancreatitis	3.84e-05	0.000133	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.78e-05	0.000132	CbGpPWpGaD
Methotrexate—SLCO1A2—Transmembrane transport of small molecules—ALB—pancreatitis	3.78e-05	0.000131	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PNLIP—pancreatitis	3.76e-05	0.000131	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PRSS3—pancreatitis	3.76e-05	0.000131	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—LPL—pancreatitis	3.74e-05	0.00013	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—KRAS—pancreatitis	3.71e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	3.7e-05	0.000129	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADH4—pancreatitis	3.7e-05	0.000129	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—KRAS—pancreatitis	3.68e-05	0.000128	CbGpPWpGaD
Methotrexate—DHFR—Disease—INS—pancreatitis	3.67e-05	0.000128	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—PDGFA—pancreatitis	3.66e-05	0.000127	CbGpPWpGaD
Methotrexate—PGD—Disease—TGFB1—pancreatitis	3.63e-05	0.000126	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALDH2—pancreatitis	3.59e-05	0.000125	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	3.58e-05	0.000124	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	3.57e-05	0.000124	CbGpPWpGaD
Methotrexate—SLC22A6—Transmembrane transport of small molecules—ALB—pancreatitis	3.56e-05	0.000124	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PPARG—pancreatitis	3.53e-05	0.000123	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	3.48e-05	0.000121	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRSS1—pancreatitis	3.48e-05	0.000121	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—INS—pancreatitis	3.46e-05	0.00012	CbGpPWpGaD
Methotrexate—ABCC2—Transmembrane transport of small molecules—ALB—pancreatitis	3.44e-05	0.00012	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PPARG—pancreatitis	3.44e-05	0.00012	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—GCG—pancreatitis	3.44e-05	0.00012	CbGpPWpGaD
Methotrexate—MTHFR—Disease—MDM2—pancreatitis	3.44e-05	0.000119	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—LPL—pancreatitis	3.44e-05	0.000119	CbGpPWpGaD
Methotrexate—ABCC1—Transmembrane transport of small molecules—ALB—pancreatitis	3.4e-05	0.000118	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	3.4e-05	0.000118	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—INS—pancreatitis	3.38e-05	0.000117	CbGpPWpGaD
Methotrexate—ALB—Metabolism—XDH—pancreatitis	3.37e-05	0.000117	CbGpPWpGaD
Methotrexate—PGD—Disease—KRAS—pancreatitis	3.36e-05	0.000117	CbGpPWpGaD
Methotrexate—AOX1—Disease—MDM2—pancreatitis	3.36e-05	0.000117	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HGF—pancreatitis	3.31e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	3.31e-05	0.000115	CbGpPWpGaD
Methotrexate—MTHFR—Disease—PTGS2—pancreatitis	3.31e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PRSS3—pancreatitis	3.3e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PNLIP—pancreatitis	3.3e-05	0.000115	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PDGFA—pancreatitis	3.26e-05	0.000113	CbGpPWpGaD
Methotrexate—SLCO1B1—Transmembrane transport of small molecules—ALB—pancreatitis	3.24e-05	0.000112	CbGpPWpGaD
Methotrexate—AOX1—Disease—PTGS2—pancreatitis	3.24e-05	0.000112	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—NRAS—pancreatitis	3.21e-05	0.000112	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—ALB—pancreatitis	3.17e-05	0.00011	CbGpPWpGaD
Methotrexate—SLC16A1—Hemostasis—HRAS—pancreatitis	3.15e-05	0.00011	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ADH1B—pancreatitis	3.15e-05	0.000109	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PPARG—pancreatitis	3.13e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	3.13e-05	0.000109	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—HRAS—pancreatitis	3.12e-05	0.000109	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—LPL—pancreatitis	3.1e-05	0.000108	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—ALB—pancreatitis	3.1e-05	0.000108	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—GCG—pancreatitis	3.1e-05	0.000108	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—INS—pancreatitis	3.07e-05	0.000107	CbGpPWpGaD
Methotrexate—DHFR—Disease—MDM2—pancreatitis	3.05e-05	0.000106	CbGpPWpGaD
Methotrexate—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	3e-05	0.000104	CbGpPWpGaD
Methotrexate—SLC46A1—Disease—IL6—pancreatitis	2.99e-05	0.000104	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—TGFB1—pancreatitis	2.98e-05	0.000104	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.98e-05	0.000103	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.96e-05	0.000103	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—XDH—pancreatitis	2.96e-05	0.000103	CbGpPWpGaD
Methotrexate—DHFR—Disease—PTGS2—pancreatitis	2.94e-05	0.000102	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—GCG—pancreatitis	2.94e-05	0.000102	CbGpPWpGaD
Methotrexate—ABCC1—Disease—LPL—pancreatitis	2.9e-05	0.000101	CbGpPWpGaD
Methotrexate—PGD—Disease—HRAS—pancreatitis	2.86e-05	9.93e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PPARG—pancreatitis	2.85e-05	9.92e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—ALB—pancreatitis	2.82e-05	9.79e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—INS—pancreatitis	2.8e-05	9.73e-05	CbGpPWpGaD
Methotrexate—MTHFR—Metabolism—PTGS2—pancreatitis	2.77e-05	9.64e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—KRAS—pancreatitis	2.76e-05	9.61e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ADH1B—pancreatitis	2.76e-05	9.58e-05	CbGpPWpGaD
Methotrexate—PGD—Disease—IL6—pancreatitis	2.74e-05	9.51e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PPARG—pancreatitis	2.73e-05	9.5e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—GCG—pancreatitis	2.72e-05	9.47e-05	CbGpPWpGaD
Methotrexate—AOX1—Metabolism—PTGS2—pancreatitis	2.71e-05	9.42e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—LPL—pancreatitis	2.7e-05	9.38e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—INS—pancreatitis	2.68e-05	9.32e-05	CbGpPWpGaD
Methotrexate—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatitis	2.62e-05	9.11e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	2.58e-05	8.97e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—NRAS—pancreatitis	2.58e-05	8.96e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—ALB—pancreatitis	2.57e-05	8.92e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—NRAS—pancreatitis	2.52e-05	8.75e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PLA2G1B—pancreatitis	2.51e-05	8.72e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PPARG—pancreatitis	2.51e-05	8.72e-05	CbGpPWpGaD
Methotrexate—DHFR—Metabolism—PTGS2—pancreatitis	2.46e-05	8.57e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—INS—pancreatitis	2.46e-05	8.55e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—ALB—pancreatitis	2.46e-05	8.54e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—LPL—pancreatitis	2.43e-05	8.44e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—A2M—pancreatitis	2.42e-05	8.43e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	2.41e-05	8.37e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—TGFB1—pancreatitis	2.39e-05	8.32e-05	CbGpPWpGaD
Methotrexate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	2.39e-05	8.31e-05	CbGpPWpGaD
Methotrexate—ABCC4—Hemostasis—HRAS—pancreatitis	2.35e-05	8.17e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—TGFB1—pancreatitis	2.34e-05	8.13e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—LPL—pancreatitis	2.31e-05	8.02e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—NRAS—pancreatitis	2.29e-05	7.96e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PPARG—pancreatitis	2.26e-05	7.87e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—ALB—pancreatitis	2.26e-05	7.84e-05	CbGpPWpGaD
Methotrexate—SLC16A1—Metabolism—PTGS2—pancreatitis	2.24e-05	7.8e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—INS—pancreatitis	2.22e-05	7.71e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—KRAS—pancreatitis	2.22e-05	7.71e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—ALDH2—pancreatitis	2.22e-05	7.71e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PLA2G1B—pancreatitis	2.2e-05	7.64e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—KRAS—pancreatitis	2.17e-05	7.53e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.16e-05	7.51e-05	CbGpPWpGaD
Methotrexate—TYMS—Metabolism—PTGS2—pancreatitis	2.15e-05	7.48e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—LPL—pancreatitis	2.14e-05	7.43e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—TGFB1—pancreatitis	2.13e-05	7.4e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—A2M—pancreatitis	2.12e-05	7.38e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—INS—pancreatitis	2.08e-05	7.22e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—ALB—pancreatitis	2.03e-05	7.07e-05	CbGpPWpGaD
Methotrexate—SLCO1B3—Metabolism—PTGS2—pancreatitis	1.97e-05	6.86e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—KRAS—pancreatitis	1.97e-05	6.85e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PPARG—pancreatitis	1.97e-05	6.85e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALDH2—pancreatitis	1.94e-05	6.75e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—INS—pancreatitis	1.93e-05	6.72e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—HRAS—pancreatitis	1.89e-05	6.55e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—HRAS—pancreatitis	1.84e-05	6.4e-05	CbGpPWpGaD
Methotrexate—MTHFR—Disease—IL6—pancreatitis	1.8e-05	6.27e-05	CbGpPWpGaD
Methotrexate—ABCC3—Metabolism—PTGS2—pancreatitis	1.78e-05	6.19e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PPARG—pancreatitis	1.77e-05	6.16e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—ALB—pancreatitis	1.77e-05	6.16e-05	CbGpPWpGaD
Methotrexate—AOX1—Disease—IL6—pancreatitis	1.76e-05	6.13e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—INS—pancreatitis	1.74e-05	6.04e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—MDM2—pancreatitis	1.73e-05	6e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.7e-05	5.91e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PPARG—pancreatitis	1.69e-05	5.86e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—GCG—pancreatitis	1.68e-05	5.84e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—HRAS—pancreatitis	1.68e-05	5.82e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—PTGS2—pancreatitis	1.67e-05	5.79e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—INS—pancreatitis	1.65e-05	5.74e-05	CbGpPWpGaD
Methotrexate—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	1.62e-05	5.63e-05	CbGpPWpGaD
Methotrexate—DHFR—Disease—IL6—pancreatitis	1.6e-05	5.57e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—ALB—pancreatitis	1.59e-05	5.54e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PPARG—pancreatitis	1.56e-05	5.42e-05	CbGpPWpGaD
Methotrexate—SLCO1A2—Metabolism—PTGS2—pancreatitis	1.55e-05	5.39e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—INS—pancreatitis	1.53e-05	5.32e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—ALB—pancreatitis	1.52e-05	5.27e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—GCG—pancreatitis	1.47e-05	5.12e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—NRAS—pancreatitis	1.45e-05	5.05e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—ALB—pancreatitis	1.4e-05	4.88e-05	CbGpPWpGaD
Methotrexate—ABCC1—Metabolism—PTGS2—pancreatitis	1.39e-05	4.85e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—TGFB1—pancreatitis	1.35e-05	4.69e-05	CbGpPWpGaD
Methotrexate—SLCO1B1—Metabolism—PTGS2—pancreatitis	1.33e-05	4.61e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—LPL—pancreatitis	1.32e-05	4.58e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—NRAS—pancreatitis	1.3e-05	4.5e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—KRAS—pancreatitis	1.25e-05	4.35e-05	CbGpPWpGaD
Methotrexate—ABCG2—Metabolism—PTGS2—pancreatitis	1.23e-05	4.27e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—TGFB1—pancreatitis	1.2e-05	4.19e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—LPL—pancreatitis	1.16e-05	4.02e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—KRAS—pancreatitis	1.12e-05	3.88e-05	CbGpPWpGaD
Methotrexate—ALB—Hemostasis—HRAS—pancreatitis	1.06e-05	3.7e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PPARG—pancreatitis	9.63e-06	3.35e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—HRAS—pancreatitis	9.48e-06	3.3e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—INS—pancreatitis	9.44e-06	3.28e-05	CbGpPWpGaD
Methotrexate—ABCC1—Disease—IL6—pancreatitis	9.07e-06	3.15e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PPARG—pancreatitis	8.44e-06	2.93e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—INS—pancreatitis	8.27e-06	2.88e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—ALB—pancreatitis	7.59e-06	2.64e-05	CbGpPWpGaD
Methotrexate—ALB—Metabolism—PTGS2—pancreatitis	7.57e-06	2.63e-05	CbGpPWpGaD
Methotrexate—ABCB1—Metabolism—PTGS2—pancreatitis	6.64e-06	2.31e-05	CbGpPWpGaD
